Skip to main content
Log in

Interactions between 6-mercaptopurine therapy and thiopurinemethyl-transferase (TPMT) activity

  • Letters to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Weinshilboum RH, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32: 651–662

    CAS  PubMed  Google Scholar 

  2. Hale JP, Lilleyman JS (1991) Importance of mercaptopurine dose in lymphoblastic leukemia. Arch Dis Child 66: 462–466

    Google Scholar 

  3. Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44: 147–152

    Google Scholar 

  4. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336: 225–229

    Google Scholar 

  5. Weinshilboum RM, Raymond FA, Pazmino PA (1978) Human erythrocyte thiopurine methyltransferase; radiochemical microassay and biochemical properties. Clin Chim Acta 85: 323–333

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capdeville, R., Mousson, B., Bax, G. et al. Interactions between 6-mercaptopurine therapy and thiopurinemethyl-transferase (TPMT) activity. Eur J Clin Pharmacol 46, 385–386 (1994). https://doi.org/10.1007/BF00194412

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194412

Key words

Navigation